Table 3.
Variable |
All Study Participants (n = 189) |
Significant Stenosis (n = 106) |
No Significant Stenosis (n = 83) |
||||||
---|---|---|---|---|---|---|---|---|---|
C-statistics (95 % CI) | Increment in C-statistics | P value | C-statistics (95 % CI) | Increment in C-statistics | P value | C-statistics (95 % CI) | Increment in C-statistics | P value | |
Lateral MAPSE | 0.815(0.739–0.089) | 0.830(0.746–0.915) | 0.719(0.539–0.899) | ||||||
TMI | 0.639(0.540–0.737) | 0.635(0.518–0.752) | |||||||
Lateral MAPSE + TMI | 0.821(0.756–0.895) | 0.182 | 0.000 | 0.844(0.767–0.921) | 0.209 | 0.002 | |||
Hypercholesterolemia | 0.590(0.489–0.690) | 0.600(0.476–0.724) | 0.644(0.415–0.873) | ||||||
Lateral MAPSE + Hypercholesterolemia | 0.811(0.734–0.888) | 0.221 | 0.001 | 0.856(0.780–0.931) | 0.256 | 0.000 | 0.789(0.623–0.955) | 0.145 | 0.316 |
TMI + Hypercholesterolemia | 0.688(0.595–0.781) | 0.697(0.585–0.809) | |||||||
Lateral MAPSE + Hypercholesterolemia | 0.844(0.776–0.912) | 0.156 | 0.005 | 0.863(0.795–0.923) | 0.166 | 0.013 |
aThis manuscript is the authors' original work and has not been published nor has it been submitted simultaneously elsewhere.
bAll authors have checked the manuscript and have agreed to the submission.